Cash Flow - Atossa Therapeutics

Download CSV

	Year Ending Dec 2023 (Update)	Year Ending Dec 2022 (Update)	Year Ending Dec 2021 (Update)	Year Ending Dec 2020 (Update)	Year Ending Dec 2019 (Update)	Year Ending Dec 2018 (Update)	Year Ending Dec 2017 (Update)	Year Ending Dec 2016 (Update)	Year Ending Dec 2015 (Update)	Year Ending Dec 2014 (Update)
Net Income/Starting Line	-30.09	-26.96	-20.61	-17.83	-17.24	-11.40	-8.12	-6.37	-15.76	-14.66
Depreciation – Supplemental	0.02	0.01	0.02	0.05	0.05	0.04	0.13	0.30	0.27	0.56
Depreciation/Depletion	0.02	0.01	0.02	0.05	0.05	0.04	0.13	0.30	0.27	0.56
Discontinued Operations								--	0.37
Unusual Items	2.99	0.00	--	2.36	0.01		0.76	0.88	--	2.35
Other Non-Cash Items	5.36	7.12	4.83	4.06	8.62	2.30	0.62	0.88	0.84	0.70
Non-Cash Items	8.35	7.12	4.83	6.43	8.63	2.30	1.38	1.76	1.21	3.05
Accounts Receivable									--	-0.37
Inventories								--	0.01	-0.04
Prepaid Expenses	2.81	-1.54	-0.67	-0.95	-0.35	-0.26	-0.08	0.02	0.00	-0.05
Other Assets	-1.70	-1.83	-0.52	-0.63	0.00	0.07	-0.08	0.36	-0.41	-0.01
Accounts Payable	-2.16	1.25	0.13	1.30	-0.06	0.02	0.08	-0.56	0.30	0.35
Accrued Expenses	0.04	1.20	0.33	0.08	-0.13	0.24	0.09	-0.84	0.41	0.63
Other Liabilities	1.78	0.00	0.02	-0.01	-0.03	0.02	0.01	-0.06	0.02	-0.01
Changes in Working Capital	0.78	-0.93	-0.72	-0.22	-0.57	0.10	0.02	-1.07	0.33	0.49
Cash from Operating Activities	-20.94	-20.76	-16.47	-11.57	-9.13	-8.96	-6.59	-5.37	-13.95	-10.56
Purchase of Fixed Assets	-0.01	-0.03	-0.01	-0.01	-0.01	-0.11		-0.01	-0.13	-0.15
Purchase/Acquisition of Intangibles									--	-0.20
Capital Expenditures	-0.01	-0.03	-0.01	-0.01	-0.01	-0.11		-0.01	-0.13	-0.34
Sale/Maturity of Investment	--
Purchase of Investments		-4.70
Other Investing Cash Flow								--	-0.16
Other Investing Cash Flow Items, Total	--	-4.70						--	-0.16
Cash from Investing Activities	-0.01	-4.73	-0.01	-0.01	-0.01	-0.11		-0.01	-0.29	-0.34
Sale/Issuance of Common		--	69.67	33.62			6.16	4.70	9.46	13.16
Repurchase/Retirement of Common	-1.48
Common Stock, Net	-1.48	--	69.67	33.62			6.16	4.70	9.46	13.16
Sale/Issuance of Preferred					--	12.29
Preferred Stock, Net			--	4.95	--	12.29
Sale/Issuance of Common/Preferred							3.87
Options Exercised		--	-0.18	-0.01
Warrants Converted		--	43.82	--	11.34		0.75
Issuance (Retirement) of Stock, Net	-1.48	--	113.30	38.55	11.34	12.29	10.78	4.70	9.46	13.16
Long Term Debt Reduction									--	-0.10
Long Term Debt, Net									--	-0.10
Issuance (Retirement) of Debt, Net									--	-0.10
Cash from Financing Activities	-1.48	--	113.30	38.55	11.34	12.29	10.78	4.70	9.46	13.06
Net Change in Cash	-22.43	-25.49	96.82	26.97	2.20	3.22	4.19	-0.69	-4.78	2.16
Net Cash - Beginning Balance	111.00	136.49	39.66	12.69	10.49	7.27	3.03	3.72	8.50	6.34
Net Cash - Ending Balance	88.57	111.00	136.49	39.66	12.69	10.49	7.22	3.03	3.72	8.50
Cash Interest Paid						--	0.00	--	0.00	0.02

In millions of USD (except for per share items)

Source: LSEG